ECO Animal Health Group (LON:EAH) Given “Buy” Rating at Shore Capital Group

ECO Animal Health Group (LON:EAH)‘s stock had its “buy” rating reissued by Shore Capital Group in a research report issued on Wednesday,London Stock Exchange reports.

ECO Animal Health Group Price Performance

Shares of EAH stock traded up GBX 5.50 on Wednesday, reaching GBX 101. The company’s stock had a trading volume of 32,832 shares, compared to its average volume of 61,948. The stock’s fifty day simple moving average is GBX 106.17 and its 200-day simple moving average is GBX 95.41. ECO Animal Health Group has a 1 year low of GBX 50 and a 1 year high of GBX 116.90. The company has a market capitalization of £67.76 million, a price-to-earnings ratio of 23.01 and a beta of -0.05. The company has a current ratio of 3.73, a quick ratio of 2.14 and a debt-to-equity ratio of 5.97.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.